Shen, Chen
Nayak, Anmada
Neitzel, Leif R.
Adams, Amber A.
Silver-Isenstadt, Maya
Sawyer, Leah M.
Benchabane, Hassina
Wang, Huilan
Bunnag, Nawat
Li, Bin
Wynn, Daniel T.
Yang, Fan
Garcia-Contreras, Marta http://orcid.org/0000-0001-8014-7966
Williams, Charles H.
Dakshanamurthy, Sivanesan
Hong, Charles C. http://orcid.org/0000-0002-0424-8252
Ayad, Nagi G.
Capobianco, Anthony J. http://orcid.org/0000-0002-3706-6797
Ahmed, Yashi
Lee, Ethan
Robbins, David J. http://orcid.org/0000-0003-0190-2973
Funding for this research was provided by:
Foundation for the National Institutes of Health
Dwoskin cancer fund
Article History
Received: 25 June 2020
Accepted: 13 August 2021
First Online: 6 September 2021
Competing interests
: D.J.R., E.L., and A.J.C. are founders of StemSynergy Therapeutics Inc., a company commercializing small-molecule cell signaling inhibitors, including Wnt inhibitors. The remaining authors declare no competing interests.